Upgrade to SI Premium - Free Trial

Piper Jaffray Raises Price Target on Amsurg (AMSG) to $82 Following 2Q EPS Beat

August 5, 2015 9:47 AM
Piper Jaffray reiterated an Overweight rating on AmSurg (NASDAQ: AMSG), and raised the price target to $82.00 (from $72.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles